Markets took a little time to appreciate the current
cyclical and structural squeeze on profitability, but eventually got the
message. So far, that message is pain
today as the group invests to extend is leadership in digital learning through
a protracted cyclical downswing in its main markets followed by jam tomorrow as
these measures yield returns and their accompanying costs drop away as early as
FY15. This time-scale, may or may not be realistic, but having been strung
again by missed expectations, markets may first wish to see some tangible
evidence of restored organic revenue growth before wishing to reach out and
discount the ‘recovery’ in FY15 and beyond. As usual, the lightly weighted H1
provides little hard evidence on progress, with this year’s results incurring a
further £14m of restructuring charges, but offset by a slightly more favourable
phasing of US educational sales than usual in the period. Having re-arranged the reporting structure
into the somewhat opaque new divisions (including “Growth” and “Core”)
meanwhile, transparency into the businesses is not improved (FT is now ‘lost’
and is Brazil really “Growth”?), investors are therefore increasingly dependent
on the narrative from management as to whether the current investment will
actually deliver. For the moment, the focus seems to be on the cost fall-away
into 2015 rather than any particular revenue growth commitment.
Trading H1 FY14: Revenues of £2,047m (+0% organic,+2%
Acq,-9% fx) with EBITA of £75m (-40%/-£50m organic, +4% Acq, -9% fx) which was
after a -£14m increase in restructuring charges (from -£29m to -£43m); vs WYT
estimate of £73m of EBITA on a similar charge and organic revenue growth number.
By division, a heavier phasing of sales
into H1 assisted North America to a +2% organic revenue rise with EBITA +24% to
£36m notwithstanding a -28% fx drag. The new “Core” division however saw
organic sales drop by -8% (weak UK curriculum and phasing) and EBITA by -76%
(to £13m). The new “Growth” segment
(emerging market education and FT?) meanwhile is still living up to its moniker
and delivered a +4% reported sales increase and +7% organic, albeit with
reported EBITA halving from £12m to only £6m.
OUTLOOK: FY14
expected to remain a transition year with continued cyclical headwinds from US
& UK educational markets, but with lower restructuring charges, albeit
partially absorbed by additional NPD expenditure and the adverse impact of fx
movements. On a net basis, the group is
re-iterating its FY14 adj EPS forecast range of between 62-67p on the 28 Feb fx
rate ($1.666 vs the current $1.697).
Note: Net restructuring charges/benefits for FY14 are
forecast at +£136m (v -£135m in FY13) including +£126m from lower restructuring
charges, +£60m of incremental cost savings, but a -£50m increase in NPD. For FY15, the group is targeting a further
+£95m of net benefits to drop through to EBITA from +£50m reduced restructuring
plus +£45m of additional cost savings, but no additional NPD.
No comments:
Post a Comment